Advanced
Glaucoma Intervention Study. 2. Visual field test scoring and
reliability. Ophthalmol. 1994;101(8):1445-1455.
http://www.ophsource.org/periodicals/ophtha/article/PIIS0161642094311717/abstract
The AGIS Investigators. The Advanced Glaucoma Intervention
Study (AGIS): 7. The relationship between control of intraocular
pressure and visual field deterioration. (Comment in: Am J
Ophthalmol. 2000;130:490-491. UI: 20480021). Am J Ophthalmol.
2000;130(4):429-440.
www.ajo.com
www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11024415&dopt=Abstract
The AGIS Investigators. The Advanced Glaucoma Intervention Study
(AGIS): 9. Comparison of glaucoma outcomes in black and white
patients within treatment groups. Am J Ophthalmol. 2001;132(3):311-320.
www.ajo.com
www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11530042&dopt=Abstract
The AGIS Investigators. The Advanced Glaucoma Intervention Study
(AGIS): 11. Risk factors for failure of trabeculectomy and argon
laser trabeculoplasty. Am J Ophthalmol. 2002;134(4):481-498.
www.ajo.com
www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12383805&dopt=Abstract
Collaborative Normal-Tension Glaucoma Study Group. Comparison
of glaucomatous progression between untreated patients with normal-tension
glaucoma and patients with therapeutically reduced intraocular
pressures. Am J Ophthalmol. 1998;126(4):487-497.
www.ajo.com
www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9780093&dopt=Abstract
Collaborative Normal-Tension Glaucoma Study Group. Natural history
of normal-tension glaucoma. Ophthalmol. 2001;108(2):247-253.
http://www.ophsource.org/periodicals/ophtha/article/PIIS0161642000005182/abstract
Drance S, Anderson DR, Schulzer M, for the Collaborative Normal-Tension
Glaucoma Study Group. Risk factors for progression of visual field
abnormalities in normal-tension glaucoma. Am J Ophthalmol.
2001;131(6):699-708.
www.ajo.com
www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11384564&dopt=Abstract
Feiner L, Piltz-Seymour JR. Collaborative Initial Glaucoma Treatment
Study: A summary of results to date. Curr Opin Ophthalmol.
2003;14(2):106-111.
www.co-ophthalmology.com
www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12698052&dopt=Abstract
Gordon MO, Beiser JA, Brandt JD, et al, for the Ocular Hypertension
Treatment Study Group. The Ocular Hypertension Treatment Study:
Baseline factors that predict the onset of primary open-angle
glaucoma. Arch Ophthalmol. 2002;120:714-720.
http://archopht.ama-assn.org/cgi/content/abstract/120/6/714
Heijl A, Leske MC, Bengtsson B, et al, for the Early Manifest
Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma
progression: Results from the Early Manifest Glaucoma Trial.
Arch Ophthalmol. 2002;120:1268-1279.
http://archopht.ama-assn.org/cgi/content/abstract/120/10/1268
Janz NK, Wren PA, Lichter PR, et al, for the Collaborative Initial
Glaucoma Treatment Study Group. Collaborative Initial Glaucoma
Treatment Study: Interim quality of life findings after initial
medical or surgical treatment of glaucoma. Ophthalmol.
2001;108(11):1954-1965.
http://www.ophsource.org/periodicals/ophtha/article/PIIS0161642001008740/abstract
Kass MA, Heuer DK, Higginbotham EJ, et al, for the Ocular Hypertension
Treatment Study Group. The Ocular Hypertension Treatment Study:
A randomized trial determines that topical ocular hypotensive
medication delays or prevents the onset of primary open-angle
glaucoma. Arch Ophthalmol. 2002;120:701-713.
http://archopht.ama-assn.org/cgi/content/abstract/120/6/701
Leske MC, Heijl A, Hussein M, et al, for the Early Manifest Glaucoma
Trial Group. Factors for glaucoma progression and the effect of
treatment: The Early Manifest Glaucoma Trial. Arch Ophthalmol.
2003;121(1):48-56.
http://archopht.ama-assn.org/cgi/content/abstract/121/1/48
Lichter PR, Musch DC, Gillespie BW, et al, for the CIGTS Study
Group. Interim clinical outcomes in the Collaborative Initial
Glaucoma Treatment Study comparing initial treatment randomized
to medications or surgery. Ophthalmol. 2001;108(11):1943-1953.
http://www.ophsource.org/periodicals/ophtha/article/PIIS0161642001008739/abstract
ImproMED provides links to related sites as a resource for users
of our website. ImproMED does not take responsibility for the
content of these sites. These links do not imply endorsement of
these sites and ImproMED does not guarantee the credibility of
the services provided on these sites. The use of these links is
at the user's own risk. ImproMED does not ensure the protection
of personal information users provide to these third party sites.
Advanced Glaucoma Intervention Study (AGIS)
www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=49
American Academy of Ophthalmology (AAO)
www.aao.org
American Journal of Ophthalmology
www.ajo.com
American Society of Cataract & Refractive Surgery
www.ascrs.org
Archives of Ophthalmology
www.archophthalmol.com
Association for Research in Vision and Ophthalmology
www.arvo.org
Collaborative Initial Glaucoma Treatment Study (CIGTS)
www.nei.nih.gov/neitrials/static/study50.asp
Collaborative Normal-Tension Glaucoma Study (NTGS)
www.glaucoma.org/research/milestones.html#NTGStudy
www.glaucoma.org/news/gleams_sum01.html#FourthNTG
Current Opinion in Ophthalmology
www.co-ophthalmology.com/
Early Manifest Glaucoma Trial (EMGT)
www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=31
EyeWorld
www.eyeworld.org
Glaucoma Research Foundation
www.glaucoma.org
Ocular Hypertension Treatment Study (OHTS)
www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=24
Ophthalmology
www.ophsource.org/periodicals/ophtha
Review of Ophthalmology
www.revophth.com
©2003-2005 ImproMED.
Privacy Policy/Legal
Statement/Disclaimer
